Zobrazeno 1 - 10
of 109
pro vyhledávání: '"Daniel H. Johnson"'
Autor:
Noha Abdel-Wahab, Houssein Safa, Ala Abudayyeh, Daniel H. Johnson, Van Anh Trinh, Chrystia M. Zobniw, Heather Lin, Michael K. Wong, Maen Abdelrahim, A. Osama Gaber, Maria E. Suarez-Almazor, Adi Diab
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 7, Iss 1, Pp 1-10 (2019)
Abstract Background Checkpoint inhibitors (CPIs) have revolutionized the treatment of cancer, but their use remains limited by off-target inflammatory and immune-related adverse events. Solid organ transplantation (SOT) recipients have been excluded
Externí odkaz:
https://doaj.org/article/1e5b8723c93a4ea8a65ace19e65e5634
Autor:
Noha Abdel-Wahab, Houssein Safa, Ala Abudayyeh, Daniel H. Johnson, Van Anh Trinh, Chrystia M. Zobniw, Heather Lin, Michael K. Wong, Maen Abdelrahim, A. Osama Gaber, Maria E. Suarez-Almazor, Adi Diab
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 7, Iss 1, Pp 1-1 (2019)
Following publication of the original article [1], the authors reported an error in the Acknowledgments section. It should be read: ‘We are grateful to Mohsin Shah from the Department of Emergency Medicine at The University of Texas MD Anderson Can
Externí odkaz:
https://doaj.org/article/0baceb951406421d9e20711309a6c018
Autor:
Daniel H. Johnson, Chrystia M. Zobniw, Van A. Trinh, Junsheng Ma, Roland L. Bassett Jr, Noha Abdel-Wahab, Jaime Anderson, Jennifer E. Davis, Jocelyn Joseph, Marc Uemura, Ali Noman, Hamzah Abu-Sbeih, Cassian Yee, Rodabe Amaria, Sapna Patel, Hussein Tawbi, Isabella C. Glitza, Michael A. Davies, Michael K. Wong, Scott Woodman, Wen-Jen Hwu, Patrick Hwu, Yinghong Wang, Adi Diab
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 7, Iss 1, Pp 1-1 (2019)
Following publication of the original article [1], the authors reported an error in their listed affiliations.
Externí odkaz:
https://doaj.org/article/0c32dd94f7384e98a2e2da19f6b5122f
Autor:
Namrata Singh, Maria E Suarez-Almazor, Iman Osman, Jeffrey Weber, Adi Diab, Petros Grivas, Noha Abdel-Wahab, Ala Abudayyeh, Huifang Lu, Osama Rahma, Daniel H Johnson, Chrystia M Zobniw, Van A Trinh, Juhee Song, Jeffrey A Sparks, Sabina Sandigursky, Maya Dimitrova, May Daher, Maryam Buni, Kaysia Ludford, Faisal Fa'ak, Sarah H Chung, Uma Thanarajasingam, Adewunmi Falohun, Muhammad Osama Awiwi, Nourel Hoda Tahon, Khaled M Elsayes, Emma J Montazari, Julia Chernis, Osama Abu-Shawer, Ashley M Zeman, Rafee Talukder, Jean H Tayar
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 11, Iss 6 (2023)
Background Management of immune-related adverse events (irAEs) is important as they cause treatment interruption or discontinuation, more often seen with combination immune checkpoint inhibitor (ICI) therapy. Here, we retrospectively evaluated the sa
Externí odkaz:
https://doaj.org/article/a43e4d1fdb674d64bed3cf237bf2c36f
Timing of steroid initiation and response rates to immune checkpoint inhibitors in metastatic cancer
Autor:
Richa Goel, Zoe Blake, Daniel H Johnson, Karine Tawagi, Victoria Simenson, Helen Yuan, Cameron Parent, Adi Bamnolker, Diana V Maslov, Madhav KC, Marc R Matrana
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 9, Iss 7 (2021)
Background Corticosteroids (CS) are the mainstay of immune-related adverse effect (irAE) management, as well as for other indications in cancer treatment. Previous studies evaluating whether CS affect immune checkpoint inhibitor (CPI) efficacy compar
Externí odkaz:
https://doaj.org/article/7e05a514ecb848528e1b3ad38629794a
Autor:
Adi Diab, Chantale Bernatchez, Joseph Markowitz, Igor Puzanov, Gary Doolittle, Sudhir Agrawal, Nashat Gabrail, Patrick Hwu, Willem W. Overwijk, Michael T. Tetzlaff, Denái R. Milton, Srinivas K. Chunduru, Shah Rahimian, Michael A. Davies, Montaser Shaheen, Douglas B. Johnson, Robert H.I. Andtbacka, Marihella James, Houssein Safa, Courtney W. Hudgens, Marc I. Uemura, Salah-Eddine Bentebibel, Ravi Murthy, Daniel H. Johnson, Cara Haymaker
Supplementary Data from Tilsotolimod with Ipilimumab Drives Tumor Responses in Anti–PD-1 Refractory Melanoma
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::185cb271c5418b269f392ceae19bb35f
https://doi.org/10.1158/2159-8290.22539203.v1
https://doi.org/10.1158/2159-8290.22539203.v1
Autor:
Adi Diab, Chantale Bernatchez, Joseph Markowitz, Igor Puzanov, Gary Doolittle, Sudhir Agrawal, Nashat Gabrail, Patrick Hwu, Willem W. Overwijk, Michael T. Tetzlaff, Denái R. Milton, Srinivas K. Chunduru, Shah Rahimian, Michael A. Davies, Montaser Shaheen, Douglas B. Johnson, Robert H.I. Andtbacka, Marihella James, Houssein Safa, Courtney W. Hudgens, Marc I. Uemura, Salah-Eddine Bentebibel, Ravi Murthy, Daniel H. Johnson, Cara Haymaker
Many patients with advanced melanoma are resistant to immune checkpoint inhibition. In the ILLUMINATE-204 phase I/II trial, we assessed intratumoral tilsotolimod, an investigational Toll-like receptor 9 agonist, with systemic ipilimumab in patients w
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::1cbe30284e2c5a973c4196349298f34e
https://doi.org/10.1158/2159-8290.c.6549014.v1
https://doi.org/10.1158/2159-8290.c.6549014.v1
Autor:
Adi Diab, Chantale Bernatchez, Joseph Markowitz, Igor Puzanov, Gary Doolittle, Sudhir Agrawal, Nashat Gabrail, Patrick Hwu, Willem W. Overwijk, Michael T. Tetzlaff, Denái R. Milton, Srinivas K. Chunduru, Shah Rahimian, Michael A. Davies, Montaser Shaheen, Douglas B. Johnson, Robert H.I. Andtbacka, Marihella James, Houssein Safa, Courtney W. Hudgens, Marc I. Uemura, Salah-Eddine Bentebibel, Ravi Murthy, Daniel H. Johnson, Cara Haymaker
Supplementary Table from Tilsotolimod with Ipilimumab Drives Tumor Responses in Anti–PD-1 Refractory Melanoma
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1bb4c1a73b91e0259a3295525b069242
https://doi.org/10.1158/2159-8290.22539194
https://doi.org/10.1158/2159-8290.22539194
Publikováno v:
Acta Geotechnica. 16:3027-3039
Macroscopic frictional behavior of granular materials is of great importance for studying several complex problems associated with fault slip and landslides. The main objective of this study is to model the macroscale frictional behavior of granular
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::5e7ebe2e1c859c60f2cf606d573359dd
https://doi.org/10.1007/s11440-021-01224-7
https://doi.org/10.1007/s11440-021-01224-7
Autor:
Yifan Zhou, Yusra B. Medik, Bhakti Patel, Daniel B. Zamler, Sijie Chen, Thomas Chapman, Sarah Schneider, Elizabeth M. Park, Rachel L. Babcock, Taylor T. Chrisikos, Laura M. Kahn, Allison M. Dyevoich, Josue E. Pineda, Matthew C. Wong, Aditya K. Mishra, Samuel H. Cass, Alexandria P. Cogdill, Daniel H. Johnson, Sarah B. Johnson, Khalida Wani, Debora A. Ledesma, Courtney W. Hudgens, Jingjing Wang, Md Abdul Wadud Khan, Christine B. Peterson, Aron Y. Joon, Weiyi Peng, Haiyan S. Li, Reetakshi Arora, Ximing Tang, Maria Gabriela Raso, Xuegong Zhang, Wai Chin Foo, Michael T. Tetzlaff, Gretchen E. Diehl, Karen Clise-Dwyer, Elizabeth M. Whitley, Matthew M. Gubin, James P. Allison, Patrick Hwu, Nadim J. Ajami, Adi Diab, Jennifer A. Wargo, Stephanie S. Watowich
Publikováno v:
The Journal of experimental medicine. 220(2)
Immune checkpoint blockade (ICB) has revolutionized cancer treatment, yet quality of life and continuation of therapy can be constrained by immune-related adverse events (irAEs). Limited understanding of irAE mechanisms hampers development of approac
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::dd3f2ab36b1e8f26732341aaaebcd8d1
https://pubmed.ncbi.nlm.nih.gov/36367776
https://pubmed.ncbi.nlm.nih.gov/36367776